Solara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation in funds raised through Rights issue for the quarter ended March 31, 2026
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Solara Active Pharma Sciences has confirmed there is no deviation or variation in the utilization of funds raised through its Rights Issue. The company raised Rs. 309.79 crores through partly paid-up Rights Equity Shares, with Rs. 155.31 crores collected through the first call money. As of March 31, 2026, Rs. 233.61 crores was allocated for repayment of borrowings and Rs. 112.24 crores for general corporate purposes. Of the total funds, Rs. 1.20 crores remains unutilized in the monitoring agency account. The Audit Committee reviewed and approved the statement without any comments. CRISIL Ratings Limited is the monitoring agency.
Positive signal for investors as the company has utilized rights issue proceeds as stated in the Letter of Offer without any deviation. Only a small amount (Rs. 1.20 crores) remains pending utilization, which will be deployed in upcoming quarters.